These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2774597)

  • 1. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
    Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
    Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A; Poulsen H
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.
    Rosenberg P; Urwitz H; Johannesson A; Ros AM; Lindholm J; Kinnman N; Hultcrantz R
    J Hepatol; 2007 Jun; 46(6):1111-8. PubMed ID: 17399848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
    Mathew J; Leong MY; Morley N; Burt AD
    BMC Dermatol; 2005 Nov; 5():12. PubMed ID: 16316460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriatic arthritis: clinical response and side effects to methotrexate therapy.
    Espinoza LR; Zakraoui L; Espinoza CG; Gutiérrez F; Jara LJ; Silveira LH; Cuéllar ML; Martínez-Osuna P
    J Rheumatol; 1992 Jun; 19(6):872-7. PubMed ID: 1404123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
    Lenler-Petersen P; Søgård H; Thestrup-Pedersen K; Zachariae H
    Acta Derm Venereol; 1982; 62(5):448-9. PubMed ID: 6183903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
    Gilbert SC; Klintmalm G; Menter A; Silverman A
    Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.
    Rau R; Karger T; Herborn G; Frenzel H
    J Rheumatol; 1989 Apr; 16(4):489-93. PubMed ID: 2473207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate hepatotoxicity and concentrations of methotrexate and folate in erythrocytes--relation to liver fibrosis and cirrhosis.
    Zachariae H; Schrøder H; Foged E; Søgaard H
    Acta Derm Venereol; 1987; 67(4):336-40. PubMed ID: 2445154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis-liver-methotrexate interactions.
    Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
    [No Abstract]   [Full Text] [Related]  

  • 14. Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous alpha1-antitrypsin deficiency.
    Mathew J; Igbokwe UO; Morley N; Burt AD
    Dermatology; 2006; 213(2):147-9. PubMed ID: 16902293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The canals of hering might represent a target of methotrexate hepatic toxicity.
    Hytiroglou P; Tobias H; Saxena R; Abramidou M; Papadimitriou CS; Theise ND
    Am J Clin Pathol; 2004 Mar; 121(3):324-9. PubMed ID: 15023035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic metabolic function in patients receiving long-term methotrexate therapy: comparison with topically treated psoriatics, patient controls and cirrhotics.
    Birnie GG; Fitzsimons CP; Czarnecki D; Cooke A; Scobie G; Brodie MJ
    Hepatogastroenterology; 1985 Aug; 32(4):163-7. PubMed ID: 2865199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate for psoriasis: current European practice. A postal survey.
    Boffa MJ
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):196-202. PubMed ID: 15752290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
    Krishna Sumanth M; Sharma VK; Khaitan BK; Kapoor A; Tejasvi T
    Int J Dermatol; 2007 Feb; 46(2):218-23. PubMed ID: 17269983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H; Grunnet E; Sogaard H
    Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.